These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2202008)

  • 1. Safety considerations in MR imaging.
    Kanal E; Shellock FG; Talagala L
    Radiology; 1990 Sep; 176(3):593-606. PubMed ID: 2202008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AAPM/RSNA physics tutorial for residents. MR imaging safety considerations. Radiological Society of North America.
    Price RR
    Radiographics; 1999; 19(6):1641-51. PubMed ID: 10555679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
    Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
    Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy.
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Langer M; Claussen C; Felix R
    Radiology; 1991 Feb; 178(2):503-8. PubMed ID: 1987615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W
    Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety aspects of radiofrequency power deposition in magnetic resonance.
    Schaefer DJ
    Magn Reson Imaging Clin N Am; 1998 Nov; 6(4):775-89. PubMed ID: 9799855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadopentetate dimeglumine: observations on the clinical research process.
    Kieffer SA
    Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
    [No Abstract]   [Full Text] [Related]  

  • 9. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance safety.
    Simmons A; Hakansson K
    Methods Mol Biol; 2011; 711():17-28. PubMed ID: 21279596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of MR imaging contrast agents: special report.
    Wolf GL
    Radiology; 1989 Sep; 172(3):709-10. PubMed ID: 2672095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High field body MR imaging: preliminary experiences.
    Uematsu H; Takahashi M; Dougherty L; Hatabu H
    Clin Imaging; 2004; 28(3):159-62. PubMed ID: 15158217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR safety: past, present, and future from a historical perspective.
    Budinger TF
    Magn Reson Imaging Clin N Am; 1998 Nov; 6(4):701-14. PubMed ID: 9799851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: safety, new applications, new MR agents.
    Runge VM; Wells JW
    Top Magn Reson Imaging; 1995; 7(3):181-95. PubMed ID: 7654396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial MR imaging with Gd-DTPA in neonates and young infants: preliminary experience.
    Elster AD
    Radiology; 1990 Jul; 176(1):225-30. PubMed ID: 2353096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.